OneAscent Wealth Management LLC Sells 1,490 Shares of STERIS plc (NYSE:STE)

OneAscent Wealth Management LLC reduced its stake in shares of STERIS plc (NYSE:STE - Free Report) by 52.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,366 shares of the medical equipment provider's stock after selling 1,490 shares during the quarter. OneAscent Wealth Management LLC's holdings in STERIS were worth $281,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Franklin Resources Inc. raised its stake in shares of STERIS by 171.2% in the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after acquiring an additional 529,308 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in STERIS by 30.8% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider's stock valued at $2,275,000 after acquiring an additional 2,583 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in shares of STERIS in the 3rd quarter worth approximately $9,949,000. Public Sector Pension Investment Board grew its holdings in shares of STERIS by 13.2% during the 3rd quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider's stock worth $1,039,000 after purchasing an additional 500 shares in the last quarter. Finally, Merit Financial Group LLC bought a new stake in shares of STERIS during the fourth quarter valued at approximately $260,000. Institutional investors and hedge funds own 94.69% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Stephens restated an "overweight" rating and issued a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler raised their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Finally, JMP Securities reiterated a "market outperform" rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, STERIS presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

Remove Ads

STERIS Price Performance

NYSE:STE traded up $1.72 on Wednesday, reaching $227.44. The stock had a trading volume of 170,934 shares, compared to its average volume of 528,375. The company has a market capitalization of $22.35 billion, a P/E ratio of 48.29 and a beta of 0.92. The stock has a fifty day moving average price of $223.03 and a 200-day moving average price of $220.88. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Research analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.00%. The ex-dividend date was Thursday, February 20th. STERIS's payout ratio is presently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.